Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Southgate

Showing results (151-160 of 175) with videos related to

Pageof 18
Sort By:
European Journal of Public Health|June 13, 2014
Excess winter deaths in Europe: a multi-country descriptive analysisTom Fowler, Rosamund J Southgate, Thomas Waite, et al.
Cell Death and Differentiation|January 24, 2006
A novel mechanism of CD40-induced apoptosis of carcinoma cells involving TRAF3 and JNK/AP-1 activationN T Georgopoulos, L P Steele, M J Thomson, et al.
The British Journal of Surgery|April 6, 2005
Assessing the technical skills of surgical traineesJ D Beard, B C Jolly, D I Newble, et al.
Biochimica Et Biophysica Acta|May 26, 2005
Transcriptional control of the human urothelial-specific gene, uroplakin IaG D Hall, R J Weeks, J Olsburgh, et al.
Platelets|September 16, 2006
The effect of exercise and training status on platelet activation: do cocoa polyphenols play a role?I Singh, H Quinn, M Mok, et al.
Medicine and Science in Sports and Exercise|March 3, 2005
Failure to repeatedly supercompensate muscle glycogen stores in highly trained menPatrick McInerney, Sarah J Lessard, Louise M Burke, et al.
The American Journal of Pathology|December 10, 1998
Uroplakin gene expression by normal and neoplastic human urotheliumE D Lobban, B A Smith, G D Hall, et al.
Oncogene|October 19, 1999
Relationship between E-cadherin and fibroblast growth factor receptor 2b expression in bladder carcinomasS G De Medina, Z Popov, D K Chopin, et al.
British Journal of Clinical Pharmacology|November 1, 1978
Antibacterial activity in serum and urine following oral administration in man of DL473 (a cyclopentyl derivative of rifampicin) [proceedings]A T Birmingham, A J Coleman, M L Orme, et al.
Clinical Pharmacology and Therapeutics|March 1, 1980
Metabolism and kinetics of oxaprozin in normal subjectsF W Janssen, W J Jusko, S T Chiang, et al.
Pageof 18

Showing results (151-160 of 175) with videos related to

Sort By:
Pageof 18
European Journal of Public Health|June 13, 2014
Excess winter deaths in Europe: a multi-country descriptive analysisTom Fowler, Rosamund J Southgate, Thomas Waite, et al.
Cell Death and Differentiation|January 24, 2006
A novel mechanism of CD40-induced apoptosis of carcinoma cells involving TRAF3 and JNK/AP-1 activationN T Georgopoulos, L P Steele, M J Thomson, et al.
The British Journal of Surgery|April 6, 2005
Assessing the technical skills of surgical traineesJ D Beard, B C Jolly, D I Newble, et al.
Biochimica Et Biophysica Acta|May 26, 2005
Transcriptional control of the human urothelial-specific gene, uroplakin IaG D Hall, R J Weeks, J Olsburgh, et al.
Platelets|September 16, 2006
The effect of exercise and training status on platelet activation: do cocoa polyphenols play a role?I Singh, H Quinn, M Mok, et al.
Medicine and Science in Sports and Exercise|March 3, 2005
Failure to repeatedly supercompensate muscle glycogen stores in highly trained menPatrick McInerney, Sarah J Lessard, Louise M Burke, et al.
The American Journal of Pathology|December 10, 1998
Uroplakin gene expression by normal and neoplastic human urotheliumE D Lobban, B A Smith, G D Hall, et al.
Oncogene|October 19, 1999
Relationship between E-cadherin and fibroblast growth factor receptor 2b expression in bladder carcinomasS G De Medina, Z Popov, D K Chopin, et al.
British Journal of Clinical Pharmacology|November 1, 1978
Antibacterial activity in serum and urine following oral administration in man of DL473 (a cyclopentyl derivative of rifampicin) [proceedings]A T Birmingham, A J Coleman, M L Orme, et al.
Clinical Pharmacology and Therapeutics|March 1, 1980
Metabolism and kinetics of oxaprozin in normal subjectsF W Janssen, W J Jusko, S T Chiang, et al.
Pageof 18